Luciamare Perinetti Alves Martins

• Abstract

  In South America, approximately 14 million are infected with Trypanosoma cruzi, and in Brazil, around three million individuals are on chronic phase arising from infections acquired in the past. From the immunological perspective, it was demonstrated that activation of macrophages by T. cruzi results in the formation of reactive oxygen species (ROS) such that the components formed by the …

  Evaluation of vitamin C effects on acute and chronic phase of Chagas Disease in mice experimentally infected with Trypanosoma Cruzi QM1 strain, AP.R

• Abstract

  The natural American trypanosomiasis transmission spreads over an area comprising the south of the United States until the province of Chubut in Argentina, though the triatomids presence isn't restricted to the American continent. Today more than 137 triatomine species are known and although all species are potentially Trypanosoma cruzi transmitters, only a few are important in public hea…

  Isolation and characterization of Trypanosoma cruzi strains from wild triatomines captured in the region of the city of Marília, AP.R

• Abstract

  Chagas disease is an endemic anthropozoonosis in 21 countries in the Americas with approximately 6 million people affected, whose etiological agent is the protozoan Trypanosoma cruzi (T. cruzi). After infection, the parasites initiate a metabolic reprogramming with the intention of accelerating intracellular multiplication, opting for a faster energy pathway to obtain ATP, the aerobic gly…

  Changes in glucose metabolism in Chagas disease: Warburg effect., BP.IC

• Abstract

  Chagas disease (CD) is an infectious disease caused by the protozoan Trypanosoma cruzi, classified by the World Health Organization not only as a neglected disease, but a public health problem in Latin America. This character is mainly due to the importance of prophylaxis in controlling the disease, since its treatment still proves to be quite challenging, with a single option available f…

  Influence of the use of Rivastigmine on the oxidative stress caused by the QM2 strain of Trypanosoma cruzi, BP.IC

• Abstract

  Chagas disease is an infectious disease caused by Trypanosoma cruzi protozoan, classified by the World Health Organization not only as a neglected infirmity but as also a public health issue in Latin America. This character is mainly due the relevance of prevention in the control of the disease since its treatment still shows itself in a very challenging way. Despite the fact that the mai…

  Influence of galantamine in the oxidative stress caused by the QM2 strain of Trypanosoma Cruzi, BP.IC

(Only some records are available in English at this moment)

• Abstract

  Chagas disease is an anthropozoonosis endemic in 21 countries in the Americas, whose etiological agent is the protozoan Trypanosoma cruzi (T. cruzi). After infection, the parasites begin metabolic reprogramming with the intention of accelerating intracellular multiplication, opting for a faster energy pathway to obtain ATP, such as the aerobic glycolysis pathway, characterizing the Warbur…

  VERIFICATION OF THE MANIFESTATION OF THE WARBURG EFFECT IN THE EVOLUTION OF CHAGAS DISEASE, BE.EP.IC